目的：验证国产溴莫尼定滴眼液治疗原发性开角型青光眼和高眼压症的治疗价值。
AIM: To investigate the therapeutic value of domestic brimonidine in treating patients with primary open Angle glaucoma (POAG) or ocular hypertension (OHT).
方法选择开角型青光眼和高眼压症患者50例50眼，随机分为美开朗组和噻吗心安组2组，各25例25眼。
Methods 50 patients (50 eyes) with primary open angle glaucoma or ocular hypertension were randomized, 25 (25 eyes) to cartelol, another 25 (25 eyes) to timolol.
结论：国产溴莫尼定滴眼液对于控制原发性开角型青光眼和高眼压症的眼压是有效和安全的，效果与进口制剂相当。
CONCLUSION: brimonidine made domestically is effective and safe in reducing IOP of POAG and OHT, possessing equivalent efficacy with brimonidine imported.
结论：国产溴莫尼定滴眼液对于控制原发性开角型青光眼和高眼压症的眼压是有效和安全的，效果与进口制剂相当。
CONCLUSION: brimonidine made domestically is effective and safe in reducing IOP of POAG and OHT, possessing equivalent efficacy with brimonidine imported.
应用推荐